Full-Time

Utilities Maintenance Technician

LFB

LFB

1,001-5,000 employees

Public health biopharmaceuticals via plasma-derived products

No salary listed

Lille, France

In Person

Bachelor's

Category
General Maintenance & Repair (1)
Required Skills
HVAC

Get referred to LFB

See people who can refer or advise you

Requirements
  • A Bac +2 qualification in industrial maintenance is required.
  • A first successful experience in a similar utilities position is required, particularly in industrial refrigeration, HVAC, or CVC systems.
  • The role requires collaborative work.
  • The role requires good communication skills.
Responsibilities
  • Monitor the technical condition of installations, perform periodic readings when necessary, and analyze the results.
  • Carry out preventive, corrective, and improvement maintenance on installations.
  • Diagnose basic causes of stoppages and malfunctions and intervene on equipment through troubleshooting, restoration, adjustment, and related work in accordance with applicable processes and documents.
  • Record maintenance activities in the computerized maintenance management system to maintain technical tracking and history.
  • Participate in developing and improving operating procedures and in writing technical, expert, and maintenance-range reports.
  • Propose improvements to installations or procedures in partnership with support services.
  • Alert the relevant service when specific technical problems arise, implement short-term solutions, and propose and participate in longer-term solutions to improve installation safety and performance.
  • Participate in organizing and scheduling maintenance activities and operations.
  • Monitor suppliers and subcontractors during external interventions.
  • Participate in new projects and the installation of new equipment, including qualification activities.

LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Courcebœufs, France

Founded

1994

Get referred to LFB

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Arras released first medicines in 2025, proving commercialization after heavy capital spending.
  • LFB signed a 2026 collaboration with Sartorius to accelerate client programs and GMP manufacturing.
  • France 2030 funding and the 2026 Alès expansion add capacity and roughly fifty jobs.

What critics are saying

  • EFS must raise plasma collections to 1.4 million liters by 2028 or Arras underutilizes.
  • LFB BIOMANUFACTURING still depends on Sartorius for cell line development, limiting full-stack control.
  • A single French industrial base creates existential exposure to contamination, recalls, or regulatory shutdowns.

What makes LFB unique

  • French state-owned sole domestic plasma fractionator anchors national medicine supply.
  • Arras plant, authorized in 2025, centralizes production and triples plasma-derived capacity.
  • Europlasma and Amber Plasma give LFB 24 Central European collection centers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Remote Work Options

Unlimited Paid Time Off

Flexible Work Hours

Paid Vacation

Hybrid Work Options

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

Conference Attendance Budget

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Education allowance

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

7%

1 year growth

7%

2 year growth

6%
MyPharma Editions
May 30th, 2024
LFB Acquires Amber Plasma in Czech Republic

Title: "LFB Acquires Amber Plasma in the Czech Republic" LFB and its subsidiary Europlasma have acquired Amber Plasma, which operates 12 plasma collection centers in the Czech Republic. This acquisition increases Europlasma's total to 24 centers in Central Europe, enhancing LFB's plasma collection capacity. The move supports LFB's goal to meet growing patient demand and will aid in the launch of a new production site in Arras, France, tripling its medication production capacity.